UBS AM Portfolio holdings
UBS Asset Management (UBS AM), a division of UBS Group AG with origins tied to the bank’s founding in 1862, is headquartered in Zurich, Switzerland, and manages hundreds of billions in assets for institutional, intermediary, and wealth management clients globally. Specializing in a broad range of investment strategies—including equities, fixed income, multi-asset, alternatives, and sustainable investing—UBS AM leverages the firm’s extensive research capabilities and global network to deliver tailored solutions. Known for its focus on risk management and innovation, it offers products like ETFs, index funds, and private market investments, catering to diverse needs from pension funds to high-net-worth individuals. As part of UBS’s broader ecosystem, UBS AM combines Swiss precision with a commitment to ESG principles, solidifying its position as a leader in the asset management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$321M |
| 2 |
ESRX
Express Scripts Holding Company
ESRX
|
+$214M |
| 3 |
Zimmer Biomet
ZBH
|
+$207M |
| 4 |
Ecolab
ECL
|
+$192M |
| 5 |
MHFI
MCGRAW-HILL FINANCIAL INC COM
MHFI
|
+$189M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
WBA
Walgreens Boots Alliance
WBA
|
+$251M |
| 2 |
PCP
PRECISION CASTPARTS CORP
PCP
|
+$225M |
| 3 |
AGN
Allergan Inc
AGN
|
+$221M |
| 4 |
Apple
AAPL
|
+$201M |
| 5 |
American Express
AXP
|
+$180M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 16.57% |
| 2 | Technology | 14.63% |
| 3 | Financials | 14.16% |
| 4 | Consumer Discretionary | 9.69% |
| 5 | Industrials | 8.42% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1926
Tennant Co
TNC
$1.26B
| $494K | ﹤0.01% |
7,554
+100
| +1% | +$6.66K |
|
|
NTUS
1927
DELISTED
Natus Medical Inc
NTUS
| $493K | ﹤0.01% |
12,499
+700
| +6% | +$25.8K |
|
1928
Kulicke & Soffa
KLIC
$4.78B
| $492K | ﹤0.01% |
31,497
+1,600
| +5% | +$24.9K |
|
1929
Stepan Co
SCL
$1.48B
| $492K | ﹤0.01% |
11,800
+500
| +4% | +$19.9K |
|
|
WAIR
1930
DELISTED
WESCO Aircraft Holdings Inc.
WAIR
| $492K | ﹤0.01% |
32,098
+2,200
| +7% | +$31.5K |
|
|
TIVO
1931
DELISTED
TIVO INC
TIVO
| $490K | ﹤0.01% |
46,196
+3,300
| +8% | +$35.7K |
|
1932
Independent Bank
INDB
$3.97B
| $487K | ﹤0.01% |
11,100
+3,800
| +52% | +$156K |
|
1933
LCI Industries
LCII
$2.65B
| $486K | ﹤0.01% |
7,899
+300
| +4% | +$16.5K |
|
|
EBIX
1934
DELISTED
Ebix Inc
EBIX
| $483K | ﹤0.01% |
15,899
+500
| +3% | +$12.6K |
|
1935
Aramark
ARMK
$14.7B
| $481K | ﹤0.01% |
+21,076
| New | +$483K |
|
|
LUMO
1936
DELISTED
Lumos Pharma, Inc. Common Stock
LUMO
| $478K | ﹤0.01% |
970
+33
| +4% | +$12.8K |
|
1937
Standex International
SXI
$4.12B
| $476K | ﹤0.01% |
5,800
+200
| +4% | +$14.8K |
|
1938
Invesco QQQ Trust
QQQ
$484B
| $475K | ﹤0.01% |
4,500
+2,400
| +114% | +$252K |
|
1939
OneSpan
OSPN
$618M
| $474K | ﹤0.01% |
21,998
-700
| -3% | -$16.6K |
|
1940
SunCoke Energy
SXC
$797M
| $474K | ﹤0.01% |
31,697
+1,600
| +5% | +$27.3K |
|
|
TUMI
1941
DELISTED
TUMI HLDGS INC COM
TUMI
| $474K | ﹤0.01% |
19,368
+1,400
| +8% | +$31.9K |
|
|
ANR
1942
DELISTED
Alpha Natural Resources Inc
ANR
| $474K | ﹤0.01% |
474,065
+152,773
| +48% | +$174K |
|
|
BOBE
1943
DELISTED
Bob Evans Farms, Inc.
BOBE
| $472K | ﹤0.01% |
10,199
+400
| +4% | +$21.3K |
|
|
DRII
1944
DELISTED
DIAMOND RESORTS INTL, INC
DRII
| $471K | ﹤0.01% |
14,100
+2,100
| +18% | +$65.9K |
|
1945
Otter Tail
OTTR
$3.94B
| $470K | ﹤0.01% |
14,599
+400
| +3% | +$12.7K |
|
1946
Virtus Investment Partners
VRTS
$1.1B
| $470K | ﹤0.01% |
3,594
+100
| +3% | +$14.1K |
|
|
AMAG
1947
DELISTED
AMAG Pharmaceuticals
AMAG
| $470K | ﹤0.01% |
8,599
+2,300
| +37% | +$110K |
|
1948
WD-40
WDFC
$3.15B
| $469K | ﹤0.01% |
5,300
+100
| +2% | +$8.4K |
|
|
EIGI
1949
DELISTED
Endurance International Group Holdings, Inc.
EIGI
| $467K | ﹤0.01% |
24,500
+12,100
| +98% | +$221K |
|
|
CEMP
1950
DELISTED
Cempra, Inc.
CEMP
| $467K | ﹤0.01% |
13,600
+600
| +5% | +$18K |
|
Similar funds
UBS AM's Q1 2015 Portfolio in Review
As of Q1 2015, UBS AM held 2,695 positions worth $104B, down 1.3% from $105B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
UBS AM withdrew a net $4.3B in Q1 2015, closing 72 positions and reducing 841 holdings. Its most notable exit was Allergan Inc, an estimated $221M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 17% of assets, up from 15% a quarter earlier, followed by Technology and Financials.
Against the trend, UBS AM opened a new position in Qorvo worth $36M.
- UBS AM's largest Q1 2015 buy was Qorvo: 451,878 shares worth $36M.
- UBS AM added most to Allergan plc in Q1 2015, an estimated $321M increase.
- UBS AM's biggest Q1 2015 reduction was Walgreens Boots Alliance, cutting an estimated $251M.
- UBS AM fully exited Allergan Inc in Q1 2015, selling an estimated $221M.
- UBS AM's ten largest holdings make up 14% of its $104B portfolio in Q1 2015.
- UBS AM opened 84 new positions and closed 72 in Q1 2015.
- UBS AM's portfolio value fell 1.3% quarter-over-quarter to $104B.
Based on UBS AM's 13F filing for Q1 2015, filed 4 May 2015.